CLINICAL_TRIALS
trial_result
· 2009-06-17
Clinical Trial Update: An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes [Phase 3]
Summary
This Phase 3 exploratory trial assessed safety outcomes during treatment interruption of exenatide in adults with Type 2 Diabetes Mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2009-06-17